课题基金 / 基金详情

ERYTHEMA MULTIFORME: A CLINICAL PATHOGENETIC STUDY

ERYTHEMA MULTIFORME: A CLINICAL PATHOGENETIC STUDY
多形红斑:临床发病机制研究
批准号:
3126755
负责人:
WILLIAM L WESTON
金额:
$17.75万
依托单位国家:
美国
项目类别:
财政年份:
1979
资助国家:
美国
项目状态:
已结题
起止时间:
1979-09-01 至 1987-03-31

项目摘要

项目成果

WILLIAM L WESTON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Erythema multiforme is an acute syndrome often following an infection. Our preliminary clinical pathogenetic study has demonstrated a high association of erythemia multiforme with preceding herpes simplex virus infection. Our hypothesis regarding the pathogenesis of herpes simplex-associated erythema multiforme is that it involves immune complex formation. We believe that herpes-associated erythema multiforme may pose a model of in situ immune complex formation. If herpes glycoprotein antigens are released into the circulation of these patients, it would seem reasonable that they would tend to bind to the surface of epidermal cells. Since herpes viruses are epidermotrophic these proteins are involved in the binding of the virus to the membrane of epidermal cells. Subsequent combinations of antibody with membrane-bound antigen might lead to destruction of cells in the epidermis as seen in erythema multiforme. We plan to utilize enzyme immunoassays and immunofluorescent techniques to evaluate HSV antigens and antibodies in circulating immune complexes and skin biopsies obtained from erythema multiforme patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TRAINING IN IMMUNODERMATOLOGY
  • 批准号:
    3532010
  • 项目类别:
  • 资助金额:
    $6.32万
  • 财政年份:
    1981
  • 负责人:
    WILLIAM L WESTON
  • 依托单位:
TRAINING IN IMMUNODERMATOLOGY
  • 批准号:
    3532012
  • 项目类别:
  • 资助金额:
    $3.31万
  • 财政年份:
    1981
  • 负责人:
    WILLIAM L WESTON
  • 依托单位:
TRAINING IN IMMUNODERMATOLOGY
  • 批准号:
    3532017
  • 项目类别:
  • 资助金额:
    $11.72万
  • 财政年份:
    1981
  • 负责人:
    WILLIAM L WESTON
  • 依托单位:
TRAINING IN IMMUNODERMATOLOGY
  • 批准号:
    6171421
  • 项目类别:
  • 资助金额:
    $6.17万
  • 财政年份:
    1981
  • 负责人:
    WILLIAM L WESTON
  • 依托单位:
海外基金